VENUS MEDTECH

Venus Medtech (Hangzhou) Inc. ("Venus Medtech"), is the leader in transcatheter structural heart valvular therapies in China. The company is committed to the development and commercialization of innovative medical devices in the field of structural heart disease... Venus Medtech is founded in 2009 and headquartered in Hangzhou National High-Tech Industrial Development Zone (Binjiang). In 2014, the New Bioprosthetic Aortic Valve Project gained Venus Medtech a national champion in the biomedicine sector and brought the company to prominence. The impressive progress of the company is marked by four industry-first achievements: the first company to start and complete NMPA-registered clinical studies, the first cardiovascular device approved by the NMPA Green Pathway for Innovative Medical Devices, the first created-in-China heart valve device to conclude First-in-Man clinical use in Europe, and the first company approved to establish a heart valve research institute in China. On December..

Primary location: Hangzhou China